Cargando…

Effectiveness of two extended-release buprenorphine formulations during postoperative period in neonatal rats

Information on the effectiveness of a new long-lasting buprenorphine formulation, extended-release buprenorphine, in the neonatal rat is very limited. This study compares whether a high dose of extended-release buprenorphine (XR-Hi) attenuates thermal hypersensitivity for a longer period than a low...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Mingyun, Alamaw, Eden, Jampachaisri, Katechan, Huss, Monika, Pacharinsak, Cholawat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576048/ https://www.ncbi.nlm.nih.gov/pubmed/36251720 http://dx.doi.org/10.1371/journal.pone.0276327

Ejemplares similares

Sustained release buprenorphine effectively attenuates postoperative hypersensitivity in an incisional pain model in neonatal rats (Rattus norvegicus)
por: Blaney, Alexandra, et al.
Publicado: (2021)

Lipid bound extended release buprenorphine (high and low doses) and sustained release buprenorphine effectively attenuate post‐operative hypersensitivity in an incisional pain model in mice (Mus musculus)
por: Navarro, Kaela, et al.
Publicado: (2021)

Tiletamine/zolazepam and dexmedetomidine with tramadol provide effective general anesthesia in rats
por: Limprasutr, Vudhiporn, et al.
Publicado: (2021)

Bupivacaine as a euthanasia agent for African Clawed Frogs (Xenopus laevis)
por: Navarro, Kaela, et al.
Publicado: (2022)

Mouse Anesthesia: The Art and Science
por: Navarro, Kaela L, et al.
Publicado: (2021)

Extended-release monthly buprenorphine injection
por: Cuperfain, Ari B., et al.
Publicado: (2023)

Subcutaneous Extended-Release Buprenorphine Use in Pregnancy
por: Towers, Craig V., et al.
Publicado: (2020)

Evaluation and comparison of pharmacokinetic profiles and safety of two extended-release buprenorphine formulations in common marmosets (Callithrix jacchus)
por: Fabian, Niora J., et al.
Publicado: (2023)

Forecasting of Milk Production in Northern Thailand Using Seasonal Autoregressive Integrated Moving Average, Error Trend Seasonality, and Hybrid Models
por: Punyapornwithaya, Veerasak, et al.
Publicado: (2021)

Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail
por: Velasquez, Melissa, et al.
Publicado: (2019)

Continued Posttrial Benefits of Buprenorphine Extended Release: RECOVER Study Findings
por: Boyett, Brent, et al.
Publicado: (2023)

Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder
por: Flam-Ross, Juliet M., et al.
Publicado: (2023)

Analysis of significant factors for dengue fever incidence prediction
por: Siriyasatien, Padet, et al.
Publicado: (2016)

Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail
por: Lee, Joshua D., et al.
Publicado: (2021)

Differential effects of four intramuscular sedatives on cardiorespiratory stability in juvenile guinea pigs (Cavia porcellus)
por: Sixtus, Ryan P., et al.
Publicado: (2021)

Lack of adverse effects during a target animal safety trial of extended-release buprenorphine in Fischer 344 rats
por: Cowan, Alan, et al.
Publicado: (2015)

Understanding medication oversupply and its predictors in the outpatient departments in Thailand
por: Dilokthornsakul, Piyameth, et al.
Publicado: (2014)

Cellulite Reduction by Modified Thai Herbal Compresses; A Randomized Double-Blind Trial
por: Ngamdokmai, Ngamrayu, et al.
Publicado: (2018)

Efficacy of an Anti-Cellulite Herbal Emgel: A Randomized Clinical Trial
por: Ngamdokmai, Ngamrayu, et al.
Publicado: (2021)

Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations
por: Winhusen, Theresa, et al.
Publicado: (2020)

Pilot evaluation of a novel unilateral onychectomy model and efficacy of an extended release buprenorphine product
por: Enomoto, Masataka, et al.
Publicado: (2017)

First study on assessments of farmers’ benefits under a payment program based on dairy milk quality in Thailand
por: Punyapornwithaya, Veerasak, et al.
Publicado: (2022)

Evaluation of Drug‐Drug Interaction Liability for Buprenorphine Extended‐Release Monthly Injection Administered by Subcutaneous Route
por: Kharidia, Jahnavi, et al.
Publicado: (2021)

Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 Pandemic
por: Nguyen, Thuy, et al.
Publicado: (2022)

Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period
por: Lembke, Anna, et al.
Publicado: (2019)

Pramipexole and its Extended Release Formulation for Parkinson’s Disease
por: Fishman, Paul S.
Publicado: (2011)

Input Estimation for Extended-Release Formulations Exemplified with Exenatide
por: Trägårdh, Magnus, et al.
Publicado: (2017)

Time-Series Analysis for the Number of Foot and Mouth Disease Outbreak Episodes in Cattle Farms in Thailand Using Data from 2010–2020
por: Punyapornwithaya, Veerasak, et al.
Publicado: (2022)

Postoperative respiratory depression in patients on sublingual buprenorphine: a retrospective cohort study for comparison between postoperative continuation and discontinuation of buprenorphine
por: Komatsu, Ryu, et al.
Publicado: (2022)

Factors of Interest in Extended-Release Buprenorphine: Comparisons Between Incarcerated and Non-Incarcerated Patients with Opioid Use Disorder
por: Chappuy, Mathieu, et al.
Publicado: (2021)

Injection Site Reaction to Extended-Release Buprenorphine (Sublocade(®)) for Opioid Use Disorder Fourteen Days after Administration
por: Weesner, Elizabeth, et al.
Publicado: (2022)

The introduction of a novel formulation of buprenorphine into organized health systems()()
por: Mullen, William, et al.
Publicado: (2022)

Effect of preoperative application of buprenorphine transdermal patch on analgesic requirement in postoperative period in hip and knee replacement surgeries
por: Yadav, Monu, et al.
Publicado: (2019)

Buprenorphine pharmacotherapy for the management of neonatal abstinence syndrome in methadone‐exposed neonates
por: Taleghani, Afshin A., et al.
Publicado: (2019)

Formulation and Evaluation of Extended-Release Solid Dispersion of Metformin Hydrochloride
por: Patil, SA, et al.
Publicado: (2010)

Pharmacological and clinical evidence of nevirapine immediate- and extended-release formulations
por: Ena, Javier, et al.
Publicado: (2012)

Pharmacokinetics of Rytary(®), An Extended-Release Capsule Formulation of Carbidopa–Levodopa
por: Mittur, Aravind, et al.
Publicado: (2017)

Perceptions of extended‐release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia
por: Larance, Briony, et al.
Publicado: (2020)

A Delta-Opioid Receptor Gene Polymorphism Moderates the Therapeutic Response to Extended-Release Buprenorphine in Opioid Use Disorder
por: Kranzler, Henry R, et al.
Publicado: (2020)

Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations
por: Cook, R. R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r9o681d3lmee41qmbcu6n1qmhi